#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA2183806	F	Antiapicomplexan activity against Toxoplasma gondii RH tachyzoites infected in HFF cells assessed as [3H]-uracil incorporation after 24 hrs by scintillation luminescence counter	Toxoplasma gondii	39		organism-based format	Scientific Literature
2.	ALA2354177	B	Inhibition of Wnt3A/beta-casein signaling in HEK293 cells after 8 hrs by TOPflash reporter assay	Homo sapiens	18		cell-based format	Scientific Literature
3.	ALA2354178	B	Induction of internalization of Frizzled1-GFP (unknown origin) expressed in human U2OS cells at 12.5 uM after 6 hrs by confocal microscopy	Homo sapiens	23		cell-based format	Scientific Literature
4.	ALA2354221	F	PubChem BioAssay. qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT. (Class of assay: confirmatory)		172,532		assay format	PubChem BioAssays
5.	ALA4704510	F	Antiviral activity against GFP-fused Human adenovirus 5 infected in 293beta5 cells assessed as inhibition of plaque formation incubated for 7 days by GFP reporter gene assay	Human adenovirus 5	68		organism-based format	Scientific Literature
6.	ALA4704511	A	Cytotoxicity against human A549 cells assessed as reduction in cell viability incubated for 48 hrs by alamarBlue assay	Homo sapiens	68		cell-based format	Scientific Literature
7.	ALA4704512	T	Selectivity index, ratio of CC50 for cytotoxicity against human A549 cells assessed as reduction in cell viability incubated for 48 hrs by alamarBlue assay to IC50 for antiviral activity against Human adenovirus 5 infected in 293beta5 cells assessed as inhibition of plaque formation incubated for 7 days by GFP reporter gene assay		68		cell-based format	Scientific Literature
8.	ALA4704513	F	Antiviral activity against Human adenovirus 5 infected in 293beta5 cells assessed as inhibition of plaque formation at 10 uM incubated for 7 days by GFP reporter gene assay relative to control	Human adenovirus 5	66		organism-based format	Scientific Literature
9.	ALA4821031	B	Inhibition of NS-1in Zika virus	Zika virus	69		assay format	Scientific Literature
10.	ALA4821032	B	Inhibition of envelope protein in Zika virus	Zika virus	69		assay format	Scientific Literature
11.	ALA4821033	A	Metabolic stability in rat liver microsomes	Rattus norvegicus	69		microsome format	Scientific Literature
12.	ALA4821034	A	Permeability of compound by PAMPA assay		69		assay format	Scientific Literature
13.	ALA4821035	P	Solubility of the compound		69		small-molecule physicochemical format	Scientific Literature
14.	ALA4822329	F	Antiviral activity against RSV infected in human A549 cells assessed as reduction in viral titer at 10 uM incubated for 15 hrs by immunostaining analysis	Respiratory syncytial virus	21		organism-based format	Scientific Literature
15.	ALA4822330	A	Cytotoxicity against human A549 cells assessed as reduction in cell viability incubated for 15 hrs by LDH assay	Homo sapiens	21		cell-based format	Scientific Literature
16.	ALA5135650	F	Antimicrobial activity against clinical isolate CF333-2007 Pseudomonas aeruginosa DK2 measured after 18 hrs in presence of polymyxin B by microbroth dilution assay	Pseudomonas aeruginosa	30		organism-based format	Scientific Literature
17.	ALA5135651	F	Antimicrobial activity against clinical isolate CF333-2007 Pseudomonas aeruginosa DK2 assessed as polymyxin B MIC measured after 18 hrs by microbroth dilution assay	Pseudomonas aeruginosa	30		organism-based format	Scientific Literature
18.	ALA5135652	F	Synergistic antibacterial activity against clinical isolate CF333-2007 Pseudomonas aeruginosa DK2 assessed as fractional inhibitory concentration index incubated for 18 hrs in presence of Polymyxin B	Pseudomonas aeruginosa	21		organism-based format	Scientific Literature
19.	ALA5135666	F	Antimicrobial activity against clinical isolate CF333-2007 Pseudomonas aeruginosa DK2 measured after 18 hrs by microbroth dilution assay	Pseudomonas aeruginosa	30		organism-based format	Scientific Literature